Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Prestigious World Congress of Neurology Returns In-Person to Convene World-Class Researchers in Montreal 2023-10-12 18:00
Saving on Health Insurance in Hong Kong with NowCompare.com.hk 2023-10-12 14:38
ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID TUMORS 2023-10-12 10:37
Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management 2023-10-12 09:00
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test 2023-10-12 06:00
CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites 2023-10-12 05:00
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit 2023-10-11 16:27
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich 2023-10-11 14:00
EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand 2023-10-11 12:21
Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023 2023-10-11 08:10
VISTA Eye Specialist Achieves International Recognition at European Congress 2023-10-11 08:00
JUNG KWAN JANG launches student-specialized brand I.PASS for physical strength, immunity, and memory all at once 2023-10-11 07:00
EADV Congress: Non-melanoma skin cancer killing more people than melanoma, new study finds 2023-10-11 06:01
SAFETYscan47: A Valuable Component in Revolutionizing Chemical Risk Assessments for Global Health and Safety 2023-10-10 23:10
Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF 2023-10-10 19:10
Gates Foundation Celebrates 20 Years of "Grand Challenges" With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably 2023-10-10 18:30
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer 2023-10-10 18:00
Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health 2023-10-10 15:12
Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre 2023-10-10 13:54
Fullerton Health and Connections MindHealth Recommend a Framework for Action to Enhance Mental Health at the Workplace 2023-10-10 13:39
1 109 110 111 112 113 794